BioHarvest Sciences Inc. (BHST)
BHST trades on Nasdaq. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.82
+12.35% on the day
Market cap
$41.3M
Nano cap
Revenue · 2025
$34.5M
+37.0% on 2024
Net income · 2025
-$11.1M
-32.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BHST on Nasdaq |
| Sector | The Nasdaq screener gives no sector |
| Industry | The Nasdaq screener gives no industry |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001723464 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $34.5M |
| Net income | -$11.1M |
| Operating income | -$5.6M |
| Net margin | -32.3% |
| Operating margin | -16.2% |
| Revenue growth | +37.0% |
| Cash | $23.0M |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | POS AM | 2025-12-29 |
| Latest annual report BIOHARVEST SCIENCES INC. - FORM 40-F SEC FILING | 40-F | 2026-03-31 |
| Latest quarterly / interim REPORT | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 135 recent filings. All filings on EDGAR.
Peers
No industry from the screener, so peers can't be matched.
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier